Which has grown faster, ARWR or CAI?

Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus CAI at 26.15%.

Is ARWR or CAI more profitable?

CAI runs the higher net margin — ARWR at -47.79% versus CAI at 10.62%.

Arrowhead Pharmaceuticals, Inc. (ARWR) vs Caris Life Sciences, Inc. (CAI)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Caris Life Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARWR

Arrowhead Pharmaceuticals, Inc.

$8.78B

$62.35HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

CAI

Caris Life Sciences, Inc.

$8.59B

$30.39HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ARWR vs CAI

growth of $100 · dividends reinvested · last 1y

ARWR +284.4% (+284.4%/yr)CAI +8.5% (+8.5%/yr)ARWR compounded faster over this window

ARWR CAI

ARWR vs CAI: by the numbers

•ARWR is the larger company ($8.78B vs $8.59B market cap).
•CAI is profitable (10.62% net margin) while ARWR runs a net loss (-47.79%).
•ARWR grew revenue faster over the past five years (44.14% vs 26.15% CAGR).

Metrics side by side

Valuation

Metric	ARWR	CAI
P/E ratio	N/A	84.91
Forward P/E	N/A	261.92
P/S ratio	13.12	8.68
P/B ratio	18.87	14.52
EV / EBITDA	N/A	47.99
FCF yield	N/A	1.71%

Profitability

Metric	ARWR	CAI
Gross margin	100.00%	69.66%
Operating margin	11.86%	5.56%
Net margin	-47.79%	10.62%
ROE	-68.73%	17.77%
ROIC	-12.12%	14.76%

Growth (annualized)

Metric	ARWR	CAI
Revenue CAGR (5Y)	44.14%	26.15%
Total return CAGR (5Y)	0.75%	N/A

Frequently asked

Which has grown faster, ARWR or CAI?: Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus CAI at 26.15%.
Is ARWR or CAI more profitable?: CAI runs the higher net margin — ARWR at -47.79% versus CAI at 10.62%.

Go deeper

Full ARWR analysis Full CAI analysis Interactive comparison tool

Dig into the metrics

Caris Life Sciences P/E ratio Arrowhead Pharmaceuticals ROE Caris Life Sciences ROE Arrowhead Pharmaceuticals operating margin Caris Life Sciences operating margin Arrowhead Pharmaceuticals revenue growth Caris Life Sciences revenue growth Arrowhead Pharmaceuticals free cash flow Caris Life Sciences free cash flow

Arrowhead Pharmaceuticals & Caris Life Sciences appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.